Live Webinar: Nitrosamine Impurities in Pharmaceuticals – Understanding Risks, Regulations & Control
Join HPC on Saturday, 31 October 2026 (9:00–10:30 AM PST) for a live webinar on nitrosamine impurities — risks, regulations
Blog
Discover our latest articles and insights to stay informed about industry developments,
expert knowledge, and the work we do to support our clients.
Process Chemistry Excellence: From Discovery to Commercialization In pharmaceutical development process, finding a promising drug candidate is only the beginning of the journey. The true difficulty is...
Advancing Pharmaceutical Formulation Development The formulation of pharmaceutical drugs is a crucial step for identifying the appropriate dosage form, composition and production method in the drug...
Integrated Analytical and Stability Solutions for Product Development The journey of transforming a pharmaceutical compound from discovery to commercial production is one of the most difficult...
Global Supply Chain & Strategic Sourcing Solutions for Pharmaceutical Innovation Every drug that is administered to patients relies on a well-organized network of manufacturers, suppliers, labs...
How Hayat Pharmaceuticals Consulting Helps Biotech Startups Building a biotech startup is one of the most ambitious things a scientist or entrepreneur can do. You have a molecule with potential. You...
Process Validation in 2026: Meeting FDA and EMA Expectations “Process validation is not a one-time event. It is a lifecycle commitment that links science, risk management, and regulatory...
GMP Compliance · FDA Inspection Readiness · 2026 6 GMP Compliance Gaps Regulators Always Find — And How to Close Them Before Your Next Inspection In 2026, over 60% of critical inspection findings...
eCTD Submission Format: 10 Common Mistakes That Cause Technical Rejections in 2026 eCTD Submission Format: 10 Common Mistakes That Cause Technical Rejections in 2026 By the regulatory team at Hayat...
Pharmaceutical Process Optimization: How Smart Chemistry Reduces Manufacturing Costs and Improves Scalability A pharmaceutical dossier can be scientifically sound and still fail economically. Low...